1 / 10

Asia-Pacific In-vitro Fertilization Services Market to Reach $7.1 Bn, by 2022

The Asia-Pacific IVF cycle market is characterized by improvement in standards of living, increasing number of couples delaying parenthood due to professional commitments, and trends towards financial stability. <br>Get sample copy of this report: https://www.alliedmarketresearch.com/request-sample/853.

Abhi711
Download Presentation

Asia-Pacific In-vitro Fertilization Services Market to Reach $7.1 Bn, by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Asia-Pacific In-vitro Fertilization (IVF) Services Market Opportunities and Forecasts 2014–2022

  2. Asia-Pacific In-Vitro Fertilization (IVF) Services Market–Introduction The Asia-Pacific In-vitro Fertilization Market is expected to reach $7 billion by 2022, growing at a CAGR of 13.3% from 2016 to 2022. The fresh cycle (non-donor) segment accounted for approximately three-fourths share in 2015 and is expected to maintain its dominance during the forecast period. The rapidly growing geriatric population has been a major concern for the government in most of the countries in the Asia-Pacific region. Several countries, such as Vietnam, Cambodia, and Philippines, have fertility rates of 2 births per woman, which is below the average rate of 2.1 births per woman. These countries are keen on boosting their fertility rates to maintain balance between new born and geriatric populations. Indonesia in particular had a fertility rate of 2.1 and geriatric population of about 5% of the total population in 2015. According to AgeingAsia.org, this number is anticipated to reach 74 million by 2050. Korea, which had a fertility rate of 1.25 in 2014, has announced financial support for infertility treatment. Similarly, Singapore, with fertility rate of 0.80 in 2014, has increased the subsidy for treatment to 75% of the treatment cost. These factors have been instrumental in driving the growth of the Asia-Pacific IVF cycle market.

  3. Introduction Scopeof theReport KeyBenefits KeyAudiences

  4. KeyBenefits Introduction toSmart Syringes Market • This report provides an in-depth analysis of the Asia-Pacific IVF market across twelve major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period. • The report includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market. • This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region. • The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022. • Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders. Syntheticbiologyisanovelareaofresearchthatistheamalgamationofmultipledisciplinessuch as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist innature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in themarket

  5. Table ofContents: Introduction Executive Summary Asia-pacific IVF Market Analysis India IVF Market China IVF Market Japan IVF Market Australia IVF Market New Zealand IVF Market Thailand IVF Market Singapore IVF Market Malaysian IVF Market Indonesian IVF Market Philippines IVF Market Rest Of Asia-pacific IVF Market Enquiry about report at:https://www.alliedmarketresearch.com/purchase-enquiry/853

  6. Asia-Pacific In-Vitro Fertilization (IVF) Services Market–Segments

  7. Asia-Pacific In-Vitro Fertilization (IVF) Services Market–Segments Introduction toSmart Syringes Market

  8. Asia-Pacific In-Vitro Fertilization (IVF) Services Market–Segments Introduction toSmart Syringes Market

  9. Asia-Pacific In-Vitro Fertilization (IVF) Services Market–Segments

  10. ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/asia-Pacific-in-vitro-fertilization-services-market Follow UsOn

More Related